share_log

CVS Health | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

CVS Health | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

西维斯健康 | FWP:自由书写募资说明书
美股SEC公告 ·  12/04 13:35

Moomoo AI 已提取核心信息

On December 3, 2024, CVS Health announced the pricing of $3 billion in junior subordinated notes. The offering includes $2.25 billion of 7.000% Series A Notes due 2055 and $750 million of 6.750% Series B Notes due 2054. The settlement date is set for December 10, 2024.Interest on the Series A Notes will be paid semi-annually starting March 10, 2025, and on the Series B Notes starting June 10, 2025. Both series have optional deferral of interest for up to 10 years and are subject to redemption under specific conditions.The notes are rated Baa3 by Moody's and BB+ by S&P. Joint book-running managers include Barclays, Citigroup, Goldman Sachs, and others. The offering is part of a registration statement filed with the SEC.
On December 3, 2024, CVS Health announced the pricing of $3 billion in junior subordinated notes. The offering includes $2.25 billion of 7.000% Series A Notes due 2055 and $750 million of 6.750% Series B Notes due 2054. The settlement date is set for December 10, 2024.Interest on the Series A Notes will be paid semi-annually starting March 10, 2025, and on the Series B Notes starting June 10, 2025. Both series have optional deferral of interest for up to 10 years and are subject to redemption under specific conditions.The notes are rated Baa3 by Moody's and BB+ by S&P. Joint book-running managers include Barclays, Citigroup, Goldman Sachs, and others. The offering is part of a registration statement filed with the SEC.
2024年12月3日,CVS Health宣布了30亿美元的初级次级票据的定价。此次发行包括2055年到期的22.5亿美元7.000%的A系列票据和2054年到期的7.5亿美元6.750%的b系列票据。结算日期定为2024年12月10日。A系列票据的利息将从2025年3月10日起每半年支付一次,b系列票据的利息将从2025年6月10日开始支付一次。这两个系列都有长达10年的可选延期利息,并可在特定条件下兑换。这些票据被穆迪评为Baa3,标准普尔将BB+评级。联合账面管理人包括巴克莱、花旗集团、高盛等。此次发行是向美国证券交易委员会提交的注册声明的一部分。
2024年12月3日,CVS Health宣布了30亿美元的初级次级票据的定价。此次发行包括2055年到期的22.5亿美元7.000%的A系列票据和2054年到期的7.5亿美元6.750%的b系列票据。结算日期定为2024年12月10日。A系列票据的利息将从2025年3月10日起每半年支付一次,b系列票据的利息将从2025年6月10日开始支付一次。这两个系列都有长达10年的可选延期利息,并可在特定条件下兑换。这些票据被穆迪评为Baa3,标准普尔将BB+评级。联合账面管理人包括巴克莱、花旗集团、高盛等。此次发行是向美国证券交易委员会提交的注册声明的一部分。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息